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INTRODUCTION
There is an increasing concern for the burden asso-
ciated with obesity. Although some areas of the med-
ical community, including care providers, still con-
sider obesity a cosmetic problem, the prevalence of
the disease has reached the proportion of a world-
wide epidemic (1). Obesity is a major risk factor for
several diseases, namely diabetes, hypertension and
hyperlipidemia, all contributing to cardiovascular
diseases (2, 3), reducing life expectancy (4), and ex-
pensive to manage (5). Dynamic models indicate
that life expectancy is reduced in relation to body
mass index (BMI) (6), while weight loss improves
life expectancy and leads to lifetime health and eco-
nomic benefits (7).
The morbidity from obesity-associated disorders is
not limited to somatic diseases. Most patients experi-
ence a series of psychological disturbances, enhanced
by the social stigma of obesity, and by the discrimi-
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ABSTRACT. Obesity is a major risk factor for several chronic diseases, but the burden associated with it
also extends to psychosocial areas and to perceived health status. In 1999 an observational study on health-
related quality of life in obesity was planned. The study was entirely web-based. Case Report Forms and
the individual items of 7 self-administered questionnaires were directly implemented on a general database
via an extranet system from 25 Italian centers. By December 2001, after enrolment had stopped, the
database included anthropometric, socioeconomic and clinical data of 1944 patients (78% females). Weight-
cycling was reported in over 80% of cases, overeating in 60-65%, structured physical activity in only 13-
15%. Several chronic illnesses were associated. Whereas the prevalence of diabetes and hypertension was
related to the degree of obesity, hyperlipidemia and coronary heart disease did not increase further with
increasing obesity. A disturbed psychological mood was twice more common in females. Concern for pre-
sent health was the main reason for seeking treatment in both genders; concern for body appearance was
more common in females. Male subjects were more frequently assigned to dietary counseling and phys-
ical exercise, whereas in females psychotherapy was more frequently considered. Various forms of be-
havioral approach were planned in approximately 50% of patients. Finally, very few patients were ini-
tially considered for pharmacological intervention or bariatric surgery. The study provides a compre-
hensive picture of Italian patients seeking treatment for obesity. Data on perceived health status, psycho-
logical well being, body image awareness, eating behavior disorders and psychopathological distress will
provide clues to a comprehensive assessment of obesity, the effects of treatments and reasons for failure.
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nation patients suffer in several areas of everyday life
(8-10). Anxiety and depression are often present (11-
13), although conflicting data have been reported on
their exact prevalence in the obese population (14, 15).
A few patients have a binge eating disorder (BED)
(16), which is now classified as a definite psychiatric
disturbance in the 4th edition (Text Revision) of the
American Psychiatric Association’s Diagnostic and
Statistical Manual of Mental Disorders (DSM-IV-TR)
(17), in the subcategory of “eating disorders non-oth-
erwise specified”. Finally, the treatment of obesity and
food restriction may exacerbate or produce psycho-
logical distress, which largely outweighs the benefi-
cial effects of weight reduction. 
All these factors are expected to impair the health-re-
lated quality of life (HRQL) of obese persons. The
measurement of HRQL through specific question-
naires has gained widespread consideration and is now
accepted as a major outcome of treatment in chronic
conditions (18), where life is not at risk for several
years. Obesity is a good example of such diseases, and
several studies have documented a poor HRQL in
obese subjects, both seeking and not seeking treatment
at specialist centers for their excessive body weight
(19-27). Previous studies have usually addressed a spe-
cific area of HRQL and psychological distress and a
complete assessment of mood and behavior has nev-
er been reported. In addition, sociocultural differences
are probably relevant, and only few data have been re-
ported in the Italian population (28). 
A large database was recently established in Italy
for a comprehensive measurement of HRQL, psy-
chological distress and eating behavior in obese pa-
tients. The QUality of life in Obesity: eVAluation
and DIsease Surveillance (QUOVADIS) study is an
observational study aimed at providing a complete
picture of obese patients seeking treatment at obe-
sity Italian centers. The present report identifies the
population under study in terms of sociocultural, an-
thropometric and clinical characteristics, together
with life-style and daily habits. The methodology
used to implement data into the database and the dif-
ferent questionnaires used to measure HRQL and
psychological distress are also reported.
MATERIALS AND METHODS
QUOVADIS study planning 
In 1998 a steering committee was created to orga-
nize an observational study on HRQL in obese pa-
tients seeking treatment at specialist centers, with
the funding support of Bracco Imaging Spa, Milano.
After 2 meetings where a general draft was planned,
the steering committee invited several Research Units
working on obesity in different geographical areas
of Italy to participate in the study. A general inves-
tigator meeting was organized to decide selection
criteria, to agree on a data collection form, to stan-
dardize the handling of questionnaires and man-
agement of patients. Twenty-two Italian centers with
specific interest on clinical research in obesity were
involved. They were expected to enrol approximately
1800-2000 new patients in a 12-month period. Each
center was appointed for a maximum number of pa-
tients, and stopped recruitment after completing the
allotted number.
To expedite handling of data, CINECA (Casalecchio
di Reno, Bologna, Italy), an Interuniversity Consor-
tium of 15 Italian Universities, provided an extranet
system using Advanced Multicenter Research (AMR)
methodology. AMR is a web-based application, pre-
viously developed by CINECA as a result of an ex-
tensive co-operation of clinicians, statisticians and in-
formatics, which allows the management of the whole
research using standard web-browsers. Participating
centers access the system using a personal user-ID
and password and insert patients’ data into the database
through electronic forms. High quality level of data
is guaranteed by up-front quality controls (on client
side) and consistency checks (on server side). Inves-
tigators cannot modify the information sent to the cen-
tral database. Each center has access to its own data
whereas the co-ordinating center (Servizio di Malat-
tie del Metabolismo, University of Bologna) was al-
lowed to look over the whole database, and to correct
errors after notification from peripheral centers. In
the event of changes, the system registers all the in-
formation (old and new value, modification time and
reason for change). The system is very flexible and
offers the possibility of obtaining real-time reports on
demand. A different tool (direct analysis) allows on-
line descriptive statistics and data analysis.
The database was implemented using Oracle, Re-
lease 7.3.4.4.0 (Oracle Corporation, Redwood
Shores, CA), a relational database management sys-
tem. Security is granted by the IANUS system de-
veloped by CINECA, which provides a secure sys-
tem management technology in Internet applications,
and Secure Socket Layer (SSL) to encrypt all trans-
actions.
N. Melchionda, G. Marchesini, G. Apolone, et al
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In the course of the study one center failed to enrol
patients, whereas 4 more centers entered the group
during the year 2000. The 25 centers were scattered
throughout Italy, from the north (Turin, Bozen,
Udine) to the south (Catania, Messina). 
Protocol
All obese subjects seeking treatment were eligible
for the study, provided they were not on active treat-
ment at the time of enrolment, were in the age range
between 25 and 65, agreed to fill the whole package
of self-administered questionnaires, and signed an
informed consent to participate.
The protocol included a Registration Form, to be
filled in at the time of the first visit, a Case Report
Form, a Therapeutic Program Form, a package of
questionnaires for HRQL, psychological distress and
eating behavior disorders, and a follow-up form, to
be filled in at 6- and 12-month follow-up.
The Registration Form was extremely simple, since
all patients could be enroled, provided their BMI was
in the obesity range (30 kg/m2), they were not on ac-
tive treatment for obesity at the time of enrolment, and
gave informed, signed consent to participate.
The Case Report Form included information on civ-
il and educational status, on family history of
metabolic and cardiovascular diseases, on aware-
ness of personal metabolic and cardiovascular dis-
eases, and any information on specific conditions
usually associated with obesity (sleep disorders, ar-
ticular diseases, psychological distress). It also in-
cluded detailed information on number and results
of previous attempts to lose weight, on expected
weight loss in the following 6 and 12 months, on
maximum acceptable weight and on desired weight. 
HRQL and psychological well being were tested by
self-administered questionnaires. To have a broad
spectrum of perceived health status and psy-
chopathological status, the steering committee pro-
posed the use of 7 questionnaires [Medical Outcome
Survey Short-Form 36 (SF-36), Obesity-Related
Well Being (ORWELL-98), Psychological General
Well Being Index (PGWBI), Three-Factor Eating
Questionnaire (TFEQ), Binge Eating Scale (BES),
Body Uneasiness Test (BUT), Symptom CheckList-
90 (SCL-90)].
The SF-36 (29) is a specifically constructed ques-
tionnaire to measure the full range of health status
and well being by means of 36 multiple-choice ques-
tions. It measures 8 different domains, 4 in the area
of mental health (Role Limitation-Emotional, Vi-
tality, Mental Health, and Social Functioning), and
4 in the area of physical health (Physical Function-
ing, Role Limitation-Physical, Bodily Pain, Gener-
al Health). Two comprehensive indexes of HRQL
(Mental Component Summary, Physical Component
Summary) may also be computed. Finally, it pro-
vides an estimation of the self-perception of the
change in health status during the last year. It has
been extensively validated worldwide and in its Ital-
ian version (30).
The ORWELL-97 (31) is an obesity-specific ques-
tionnaire (18 items) that was recently validated to
measure the intensity and the subjective relevance
of physical and psychological distress generated by
overweight. It is particularly useful to measure
changes in perceived health status following changes
in body weight.
The PGWBI (32) is a measure of mood and emotion-
al status reflecting subjective well being. The responses
to 22 questions are arranged in 6 affective states: anx-
iety, depressed mood, positive well-being self-control,
general health and vitality. The Italian version of the
questionnaire has been recently validated.
The TFEQ (33) includes 36 items with an agree/dis-
agree format and 15 items on 4 response scales. All
item responses are aggregated into 3 main factors:
restrained eating, disinhibition and hunger. Re-
strained eating measures the amount of intention-
al restraining on food intake; disinhibition mea-
sures the loss of control on eating pattern and so-
cial/emotional eating; hunger measures subjective
feeling of hunger. 
The BES (34) includes 16 items measuring the sever-
ity of the binge eating disorder. It examines both be-
havioral manifestations (eating large amounts of
food) and feeling/cognition during a binge episode
(loss of control, guilt, fear of being unable to stop
eating). 
Both TFEQ and BES have been translated into Ital-
ian and validated by the NetWorking Team Group
of the Italian Society for Eating Behavior Disorders
(SIS-DCA).
The BUT is a new self-administered, rapid ques-
tionnaire specifically developed to evaluate concern
for physical appearance, body image awareness (34
items) and body parts which more severely contribute
to body dissatisfaction (37 items).
The SCL-90 (35) is an easy tool to identify psy-
chopathological distress. For each item, patients
The QUOVADIS Study
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score how much that problem has distressed them
during the last week, with responses ranging from
0 (not at all) to 4 (extremely). The 90 items of the
test are summarized into 9 domains (somatization,
obsessive-compulsive thoughts, interpersonal sen-
sitivity, depression, anxiety, hostility, phobic anxi-
ety, paranoid conceiving, psychotic behavior), and
a general symptom index (GSI), which is used as an
indicator of the overall psychological distress. 
The total number of items of the 7 questionnaires is
304. A specific protocol was devised to submit ques-
tionnaires to patients at different times in the course
of the enrolment visit, to maintain their attention to
questions. The questionnaires are rigidly self-ad-
ministered, but personnel in each center were trained
to check completeness of data. Whenever data were
missing at first check, patients were asked to com-
plete the questionnaires, and instructions were giv-
en when needed, without forcing answers.
The Therapeutic Program Form included data on
planned therapeutic program for any individual pa-
tient. The study was expected to be observational.
Accordingly, centers were expected to treat patients
along the lines of their specific programs, including
dieting, cognitive behavioral therapy, drugs and
bariatric surgery.
The Follow-up Format was designed to register any
modification of body weight, clinical and laborato-
ry variables after 6 and 12 months of therapy, to-
gether with the actual treatment received by patients,
irrespective of the tentative treatment outlined in the
Therapeutic Program Form. It was also used to reg-
ister dropouts and any problem encountered by pa-
tients during the follow-up.
The protocol was approved by the Ethics Committees
of the individual centers, after approval of the ethical
committee by the coordinating center (Azienda Os-
pedaliera di Bologna, Policlinico S. Orsola - Malpighi).
Statistical analysis
Differences between gender groups were analyzed
by means of unpaired t test or rank sum test, when-
ever appropriate. X2 analysis (2 x 2 or R x C) was
used for contingency tables. Statistical significance
was set at p-values <0.05.
RESULTS
The study officially started in February 2000 and
stopped on November 31, 2001. The recruitment curve
is presented in Figure 1. As expected, the number of
patients increased steadily in the course of the year
2000, reaching a plateau by the first trimester of 2001.
At this time, the final increase in the number of en-
roled patients was almost completely due to centers
where the recruitment had started later. 
Female patients accounted for nearly 78% of the en-
roled population (Table 1), with large variations among
different centers (from 59.6 to 97.1) (p=0.0002, X2
test). There were no differences between genders in
the age distribution; also the BMI and the distribu-
tion according to the severity of obesity were similar.
Only 5-6% of the population did not reach the thresh-
old of waist circumference for the diagnosis of vis-
ceral obesity, whereas the waist-to-hip ratio was be-
low the cut-off for visceral obesity in approximate-
ly 50% of males and two thirds of females.
Male patients had a higher educational level, a dif-
ferent civil status and a different job distribution.
The large majority of both males and females had
previously been involved in weight-reducing pro-
grams, and in a few of them the number of previous
attempts was exceedingly large (Table 2). The preva-
lence of patients spending most of their time sitting
was higher in males, as was the prevalence of sub-
jects involved in tiring jobs. Only 13-15% of patients
were involved in a structured physical activity, but
very few spent at least 1 hr/day exercising. 
When patients were asked to score their life-style,
males were more likely to score it either as extreme-
N. Melchionda, G. Marchesini, G. Apolone, et al
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Fig. 1 - Registration curve in the course of the study. Males
are identified by open columns, black columns are females.
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ly sedentary or as extremely active. No differences
were present for eating patterns. Two-thirds of males
and over 60% of females admitted to eating a larger-
than-normal amount of food. The prevalence of ac-
tive or previous alcohol drinkers and cigarette smok-
ers was higher in males.
Several patients were aware of chronic illnesses
(Table 3), causing hospital admission during the
last year in 15-22% of cases. Diabetes, hyperten-
sion, hyperlipidemia and coronary heart disease
(angina, myocardial infarction, coronary by-pass)
were more frequent in males. The prevalence of
clinically significant peripheral arterial disease
was very low. Whereas diabetes and hypertension
were significantly related to the degree of obesi-
ty, for hyperlipidemia and coronary heart disease
no increase was observed in relation to increasing
severity of obesity (Fig. 2). 
Gallstone disease or previous cholecystectomy were
approximately three times more common in females,
whereas snoring was much more common in males,
with increasing prevalence in relation to obesity class
[Class I, 47.2% (95% CI, 43.5-50.9); Class II, 56.0
(95% CI, 51.6-60.1); Class III, 67.2 (95% CI 63.3-
70.7); p<0.0001]. 
The prevalence of reported pain in the hip and knee
joints was more common in females, and strictly as-
sociated to the degree of obesity (p=0.011 and
p<0.0001, respectively), reaching a prevalence of
35.2% for hip pain (95% CI, 31.4-38.9) and 51.7%
for knee pain (95% CI, 47.7-55.6) in Class III patients.
A previous diagnosis of a disturbed psychological
The QUOVADIS Study
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Table 1 - Characteristics of patients under study (mean±SD or prevalence and 95% CI).
Males Females p*
Gender 432 1512
Age (yr) (median and range) 44 (24-64) 46 (18-65) 0.098
45 yr 48.9 (44.0-53.7) 54.0 (51.4-56.5) 0.769
Body mass index (kg/m2) (median and range) 36.5 (30.0-82.2) 36.8 (30.0-70.0) 0.453
Obesity class 0.385
Class I (30-34.9 kg/m2) 41.2 (36.6-45.9) 37.7 (35.2-401)
Class II (35-39.9 kg/m2) 27.6 (23.4-31.9) 28.4 (26.1-30.7)
Class III (40 kg/m2) 31.2 (26.8-35.7) 33.9 (31.5-36.4)
Waist circumference (cm) 121±15 107±14 <0.0001
>102 cm (males) or >88 cm (females) 93.9 (90.9-95.7) 94.8 (93.5-95.8) 0.475
Waist-to-hip ratio 1.00±0.07 0.87±0.08 <0.0001
>1.0 (males) or >0.9 (females) 44.7 (39.8-49.4) 30.6 (28.1-33.1) <0.0001
Education <0.0001
Primary 10.4 (7.7-13.5) 19.8 (17.8-21.9)
Secondary 29.9 (25.6-34.3) 35.8 (33.4-38.3)
Commercial or vocational 48.9 (44.0-53.6) 37.4 (34.9-39.9)
Degree 10.8 (8.1-14.1) 7.0 (5.7-8.4)
Civil status <0.0001
Single/divorced 27.5 (23.3-31.8) 20.6 (18.6-22.7)
Married/co-habitating 71.3 (66.7-75.3) 74.0 (71.6-76.2)
Widowed 1.2 (0.4-2.6) 5.4 (4.3-6.4)
Employment status <0.0001
Student 2.2 (1.1-3.9) 1.9 (1.3-2.7)
Self-employed 27.5 (23.3-31.8) 7.6 (6.3-9.1)
Employee 38.6 (33.9-43.2) 33.2 (30.8-35.6)
Housewife - 26.1 (23.9-28.4)
Unemployed 2.9 (1.6-4.8) 3.7 (2.8-4.8)
Retired 13.2 (10.2-16.7) 13.1 (11.4-14.9)
Other 15.7 (12.4-19.3) 14.3 (12.6-16.2)
*Unpaired t test, Wilcoxon rank sum test, or X2 test.
© 200
3, E
ditr
ice
 Ku
rtis
For personal use only
mood was twice more common in the female gen-
der, whereas thyroid diseases were four times more
common. Finally, hormone-related tumors and colon
cancer had previously been diagnosed in a limited
number of patients.
When forced to select a sole item as the main rea-
son for seeking treatment for their obesity, concern
for present health was the principal reason for both
males and females. Concern for body appearance
was more likely to be a problem in females, and
mainly in female patients with Class I obesity
(20.6%; 95% CI, 17.3-24.0).
In the large majority of patients, planned treatment
was still based on dietary prescription (Table 3).
Male subjects were more frequently addressed to-
wards dietary counseling and physical exercise,
whereas in female subjects, a definite psychothera-
py was more frequently considered. Various forms
of behavioral approach (self-help, guided self-help,
psychoeducation, or a formal cognitive-behavioral
treatment) were used in approximately 50% of pa-
tients. Finally, very few patients were considered for
pharmacological intervention or bariatric surgery at
first assessment.
DISCUSSION
The present report identifies the main characteristics
of obese Italian patients seeking treatment in special-
ist centers. These centers were partly university-based,
partly non-academic, and scattered throughout Italy,
to give a comprehensive picture of the main features
N. Melchionda, G. Marchesini, G. Apolone, et al
120 DNM, Vol. 16, N. 2
Table 2 - Self-evaluation of diet history and life-style in patients under study (mean±SD or prevalence and 95% CI).
Males Females p*
Previous attempts to lose weight 72.3 (67.7-76.3) 85.4 (83.4-87.1) <0.0001
N of attempts (median) 3 (1-over 20) 4 (1-over 20) 0.0019
Daily life and job style <0.0001
Sitting 56.4 (51.5-61.0) 43.3 (40.7-45.8)
Standing 24.1 (20.1-28.3) 36.3 (33.9-38.8)
Walking 13.0 (10.0-16.5) 17.2 (15.3-19.2)
Carrying loads 4.3 (2.7-6.6) 1.5 (0.9-3.6)
Other 1.9 (0.9-3.6) 1.7 (1.1-2.4)
Structured physical activity 13.0 (10.0-16.5) 14.9 (13.1-16.8) 0.341
Hours/week (median and range) 3 (1-15) 2 (1-28) 0.0017
Self-evaluation of life-style 0.0003
Very sedentary 21.0 (17.2-25.0) 17.5 (15.6-19.6)
Moderately sedentary 37.6 (32.9-42.2) 36.0 (33.5-38.5)
Normal 23.4 (19.4-27.6) 27.5 (25.2-29.8)
Moderately active 14.7 (11.5-18.3) 18.2 (16.2-20.2)
Very active 3.4 (1.9-5.4) 0.8 (0.4-1.3)
Self-evaluation of eating pattern 0.092
Eat much less than normal 0.5 (0.1-1.5) 0.4 (0.2-0.9)
Eat less than normal 2.9 (1.6-4.8) 5.0 (4.0-6.3)
Eat a normal amount of food 28.7 (24.4-33.1) 32.4 (29.9-34.8)
Eat more than normal 45.1 (40.2-49.8) 43.9 (41.3-46.4)
Eat much more than normal 22.9 (19.0-27.0) 18.1 (16.2-20.1)
Alcohol drinkers <0.0001
Active drinkers 35.2 (30.6-39.8) 15.5 (13.7-17.4)
Previous drinkers 3.9 (2.3-6.0) 1.5 (0.9-2.2)
Cigarette smokers <0.0001
Active smokers 27.5 (23.3-31.8) 21.1 (19.0-23.3)
Previous smokers 33.3 (28.8-37.8) 19.6 (17.6-21.7)
*Mann-Whitney or X2 test.
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of obese Italians and of treatment strategies, because
of its observational planning. Selection criteria were
extremely wide, and only age range prevented the in-
clusion of the few patients who were either too young
(<25 yr) or elderly (>65 yr). According to data recently
published by one Italian center (28), which enroled
over 10% of the total present population, subjects
younger than 25 yr account for less than 10% of non-
pediatric patients seeking weight-reducing treatment
for obesity, whereas subjects older than 65 are rarely
selected for intensive programs.
The study was specifically aimed at giving a picture
of HRQL, psychological distress, eating behavior
and body image disorders, both at entry and after a
follow-up of 6 and 12 months. These data will be
presented in a specific report.
The QUOVADIS Study
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Table 3 - Awareness of physical problems, reasons for entering a weight-reducing program, and planned treatment (prevalence
and 95% CI).
Males Females p*
Hospital admission in the last year 18.6 (15.0-22.4) 17.5 (15.6-19.5) 0.616
Diabetes 12.8 (9.8-16.2) 8.3 (7.0-9.8) 0.008
Hypertension 43.9 (39.0-48.5) 34.6 (32.1-37.1) 0.0007
Hyperlipidemia 31.6 (27.2-36.1) 20.0 (18.0-22.1) <0.0001
Coronary heart disease 5.8 (3.8-8.3) 1.7 (1.2-2.5) <0.0001
Myocardial infarction 3.1 (1.8-5.1) 0.9 (0.5-1.5) 0.0007
Coronary by-pass 0.7 (0.2-1.9) 0.2 (0.1-0.6) 0.139
Peripheral vascular disease 0.2 (0.0-1.1) 0.1 (0.0-0.4) 0.665
Aorto-iliac by-pass 0.2 (0.0-1.1) 0.1 (0.0-0.3) 0.394
Carotid thrombo-endoarterectomy 0.0 (0.0-0.7) 0.1 (0.0-0.3) 0.591
Gallstones 6.0 (4.0-8.6) 15.9 (14.0-17.8) <0.0001
Cholecystectomy 3.4 (1.9-5.4) 10.2 (8.7-11.8) <0.0001
Snoring 71.3 (66.7-75.4) 52.0 (49.4-54.5) <0.0001
Hip pain 20.5 (16.8-24.5) 34.0 (31.6-36.5) <0.0001
Knee pain 29.9 (25.6-34.3) 44.1 (41.5-46.6) <0.0001
Psychopathological distress 9.9 (7.3-13.0) 20.6 (18.6-22.8) <0.0001
Previous cancer 3.4 (1.9-5.4) 8.3 (7.0-9.8) 0.0002
Uterus 4.1 (3.2-5.2) -
Breast 0.2 (0.0-1.1) 2.4 (1.7-3.3) 0.0006
Colon 0.5 (0.1-1.5) 0.6 (0.3-1.1) 0.846
Others 2.7 (1.4-4.5) 2.0 (1.4-2.9) 0.612
Thyroid diseases 4.1 (2.5-6.3) 18.2 (16.3-20.3) <0.0001
Menstrual disorders - 17.9 (16.0-19.9) -
Hirsutism - 8.0 (6.7-9.5) -
Main reason for seeking treatment <0.0001
Concern for appearance 7.2 (5.0-10.0) 17.3 (15.4-19.3)
Concern for present health 56.1 (51.2-60.7) 50.0 (47.4-52.6)
Concern for future health 36.6 (32.0-41.2) 24.7 (22.8-26.7)
Planned treatment**
Dietary prescription 76.4 (71.4-80.6) 76.3 (73.7-78.6) 0.952
Dietary counseling 51.7 (46.1-56.8) 45.5 (42.5-48.3) 0.046
Physical exercise 59.5 (53.9-64.5) 52.5 (49.3-55.1) 0.021
Behavioral approach 46.4 (40.9-51.6) 53.4 (50.4-56.2) 0.190
Psychotherapy 1.5 (0.6-3.3) 3.8 (2.8-5.0) 0.027
Drug therapy 7.8 (5.3-11.1) 7.7 (6.3-9.3) 0.937
Bariatric surgery 1.8 (0.7-3.7) 2.1 (1.4-3.1) 0.735
*X2 test. **Treatments are not mutually exclusive.
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In relation to data presented here, several points need
to be discussed. Firstly, females accounted for nearly
80% of cases. Gender distribution significantly varied
among centers, but in all centers the number of fe-
males exceeded the number of males. This fits with
all studies of obesity where patients are recruited on
the basis of self-referral for treatment (2, 25, 28), but
contrasts with epidemiological studies showing that
obesity affects males and females in nearly identical
rates, with only a modest prevalence of female gen-
der (1, 19, 26, 36). This evidence is a matter of con-
cern for specialists involved in the treatment of obe-
sity. Obesity increases cardiovascular risk, and males,
because of their visceral adiposity and lack of hor-
monal protection, are at greater risk than females. Un-
fortunately, the motivation for entering a weight-re-
ducing program is much higher and different in fe-
males; males are frequently in a pre-contemplative or
contemplative state (37), are not seriously consider-
ing the possibility of permanent life-style changes to
cope with their excessive weight, or claim they have
no time to care for their person.
Motivation is an important issue. In the present pop-
ulation, nearly 20% of females considered their body
appearance the principal reason for entering a weight-
reducing program. This figure probably underesti-
mates the importance of concern for body appear-
ance in the general population of obese females be-
cause of a referral bias to medical centers. In males,
concern for body appearance was exceedingly rare,
but were this reason equally important for males and
females, still the number of males seeking treatment
would remain much lower than that of females. Ed-
ucational programs are needed to move male obese
patients towards treatment, and to help them to re-
move obstacles and the distress about what they have
to give up to achieve change (38).
Secondly, several aspects of daily life of obese pa-
tients need comments. According to the referred
number of previous attempts to lose weight, weight-
cycling is the rule, both in males and in females,
pointing to a low compliance to weight-reducing
programs in both sexes. Also in this case a referral
bias to medical centers may increase the number of
weight-cyclers in comparison to the general obese
population. However, this evidence opens the ques-
tion what is standard treatment for obesity. Do we
need to follow patients as long as they lose weight
to a pre-definite target, or follow-up must be indef-
initely maintained to minimize dropouts and weight
regain? Apparently, present strategies do not guar-
antee long-term results.
The distribution of obesity is fairly representative of
the general trend of obesity in Italy. However, dif-
ferent centers enroled patients according to their spe-
cific protocols, and the prevalence of obesity class-
es was extremely variable. One center enroled 96%
of patients with Class III obesity, whereas another
had no patients with Class III and 79% with Class I
obesity. Far from being a bias of the study, this will
allow a more comprehensive assessment of the var-
ious strategies of treating obesity of different sever-
ity in different settings.
As expected, planned treatments were extremely
variable. The low number of patients scheduled for
bariatric surgery probably represents a recruitment
bias. All participating centers were medical centers
and, although a few of them were actively involved
in protocols of bariatric surgery, this option is prob-
ably underestimated in our series with Class III obe-
sity in comparison to the general Italian patients with
morbid obesity.
Data on life-style will allow a reasonable frame to
evaluate effectiveness of these various weight-re-
ducing strategies and HRQL. A special focus was
dedicated to physical activity, because of its prima-
ry importance on fat deposition and weight mainte-
nance after weight loss (4, 39). Although self-report
of physical activity is not very accurate (40), this is
the necessary prerequisite to activate behavioral
changes (38). This consideration also applies to self-
evaluation of eating pattern.
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Fig. 2 - Prevalence of diseases in relation to obesity class.
Class I patients have a body mass index (BMI) in the range
30-34.9 kg/m2, Class II patients have a BMI in the range
35-39.9 kg/m2 , Class III patients have a BMI40 kg/m2.
P-values (X2 test) identify differences between classes.
CHD=coronary heart disease.
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Finally, awareness of somatic diseases is of paramount
importance to ascribe impaired HRQL to obesity and
not to any complicating disease. Whereas the pres-
ence of diabetes, hypertension and hyperlipidemia
was of the same magnitude as expected, the presence
of vascular diseases, either coronary or peripheral,
was exceedingly low in the present population. These
data suggest that patients with severe disease do not
seek treatment for losing weight at obesity centers,
but are probably treated in cardiology units, with un-
known results. It is time to integrate competence to-
wards a proper management of obese patients (41).
The last consideration is for therapeutic interven-
tion. A formal dietary prescription is still consid-
ered in the majority of patients, despite its very poor
effectiveness (42), and largely exceeds the treat-
ment option of dietary counseling and behavioral
approach. A life-style behavioral program, in its
various forms, was considered in approximately
50% of cases, confirming that this approach remains
a cornerstone of therapy (43) and may be introduced
from the very beginning to be of help in weight-loss
maintenance.
As expected, a pharmacological treatment was rarely
considered at the beginning of the weight-reducing
program; it has limitations (44), but may be recon-
sidered in the weight-maintenance period after
weight loss (45). Correctly, surgical approaches,
which should be reserved for those with more seri-
ous clinical risks (45), were rarely considered in our
medical units. In the group with Class III obesity,
bariatric surgery was planned in 5.3% of cases (95%
CI, 3.8-8.1). It will be of primary importance to an-
alyze the specific indications given by different cen-
ters. Also in the area of treatment it is time to aban-
don concepts and preconcepts and move into evi-
dence-based medicine.
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